Every 8-K that AMERICAN HEALTHCARE REIT INC (AHR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow AHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AHR filings page.
American Healthcare REIT, Inc. (AHR) reported a planned CFO transition and related compensation arrangements. Brian S. Peay will retire as Chief Financial Officer effective September 30, 2026 and will become a non-employee consultant through April 15, 2027. Aric Chang, currently Chief Financial Officer, Real Estate at Public Storage, has been appointed CFO effective October 1, 2026.
Chang’s employment terms include a $500,000 annual base salary, a target annual bonus equal to 100% of base salary (pro-rated for 2026), and beginning in 2027, an annual long-term incentive award with a target grant date fair value of $1,000,000 split between restricted stock units and performance-based restricted stock units, plus a one-time $310,000 cash inducement payment. Peay will receive consulting payments equal to his base salary through 2026, a 2026 short-term incentive payout equal to 150% of his 2026 base salary, accelerated vesting of 18,159 shares of restricted stock, and $45,000 as reimbursement for expected COBRA health premiums. The company states that Peay’s retirement is not due to any disagreement regarding operations, policies or practices.
American Healthcare REIT, Inc. (AHR) announced the closing of its initial acquisitions in a large senior housing portfolio from Kensington Senior Living. AHR acquired six Class A senior housing communities for a total investment of approximately $572 million, comprising 464 units, as part of an eight-community, 745‑unit portfolio with an aggregate contract purchase price of approximately $873 million, which the company states is well below replacement cost.
The remaining two communities are under definitive purchase agreements and are expected to close in the fourth quarter of 2026, subject to specified closing conditions. AHR’s total year-to-date investments now exceed $2 billion, and its awarded investment pipeline stands at over $675 million, which it expects to fund with match funded equity proceeds from unsettled forward agreements. Approximately 93% of the portfolio’s units are dedicated to assisted living and memory care, in affluent, supply-constrained U.S. infill markets. Kensington will continue operating the communities, establishing a long-term strategic partnership aligned with AHR’s higher-acuity senior housing strategy.
American Healthcare REIT, Inc. (AHR) reports that, following its previously closed public offering of 13,250,000 shares of common stock, the underwriters exercised in full their 30‑day option to purchase an additional 1,987,500 shares. In connection with this option exercise, the company entered into separate Additional Forward Sale Agreements with Morgan Stanley & Co. LLC, Citigroup Global Markets Inc. and KeyBanc Capital Markets Inc. on August 20, 2026.
The Forward Sellers borrowed and sold 1,987,500 shares on August 24, 2026 to hedge the Forward Purchasers’ obligations. American Healthcare REIT intends, subject to settlement elections and conditions, to physically settle the Additional Forward Sale Agreements by delivering 1,987,500 shares no later than August 10, 2028 in exchange for cash based on the public offering price less underwriting discounts and commissions. The company intends to contribute the net proceeds to its Operating Partnership, which intends to use them for a pending acquisition of senior housing properties, potential future investments and general corporate purposes.
American Healthcare REIT, Inc. reported that on August 12, 2026 it closed a public offering of 13,250,000 shares of common stock, structured as a forward sale through Morgan Stanley, Citigroup and KeyBanc as underwriters, forward sellers and forward purchasers.
The underwriters received a 30‑day option to purchase up to 1,987,500 additional shares. Separate Forward Sale Agreements with the forward purchasers provide that the company may physically settle by delivering 13,250,000 shares on one or more dates it chooses no later than August 10, 2028, in exchange for cash based on the public offering price less underwriting discounts and commissions, subject to adjustments.
The company intends to contribute the net cash proceeds from settlement to its Operating Partnership for units of limited partnership interest, and the Operating Partnership intends to use those proceeds for a pending acquisition of a senior housing property portfolio, other potential future investments and general corporate purposes.
American Healthcare REIT, Inc. agreed to acquire the Kensington Portfolio, a group of eight senior housing communities in California, Maryland, New York and Virginia totaling 745 units, for an aggregate purchase price of $873,000,000, subject to prorations and adjustments. The assets are being purchased through three related purchase agreements with various Kensington-affiliated sellers.
The buyer must place deposits totaling $8,730,000 into escrow within three business days of August 10, 2026; these deposits are generally non‑refundable but credit the purchase price and may be returned in specified casualty, condemnation, default or closing‑condition scenarios. The Portfolio Agreement targets an Initial Closing on September 1, 2026, with a one‑time extension option to October 15, 2026. The Kensington Park closing depends on lender consent to an existing $56,460,000 mortgage or, absent consent, a later closing date without assuming that loan. The Bethesda closing depends on the property achieving a defined minimum annualized net operating income for three consecutive months. The company plans to finance the transaction with a mix of equity offerings, borrowings under its credit agreement, assumption of debt and cash on hand, and notes that all closings remain subject to substantial conditions and may not occur.
American Healthcare REIT, Inc. delivered strong Q2 2026 results, reporting GAAP net income attributable to controlling interest of $30.6 million, or $0.16 per diluted share, on total revenues of $674.3 million. NAREIT FFO per diluted share was $0.51 and Normalized FFO $0.54, increases of 24.4% and 28.6% year over year.
Total portfolio Same-Store NOI grew 13.2%, led by senior housing operating properties and integrated senior health campuses with 20.5% and 16.1% growth. The company completed $126.9 million of SHOP acquisitions in the quarter and $1.4 billion year to date, then post‑quarter acquired 10 additional SHOP assets for about $1.0 billion and funded an $86.2 million loan with purchase options.
Leverage improved, with Net Debt‑to‑Annualized Adjusted EBITDA declining to 2.5x and liquidity of approximately $2.6 billion. Management raised 2026 guidance, including NFFO per diluted share to $2.15–$2.19 and total portfolio Same-Store NOI growth to 11.0%–13.0%, and paid a $0.25 per‑share quarterly dividend.
American Healthcare REIT, Inc. announced CEO and leadership changes. Danny Prosky retired as Chief Executive Officer and President effective July 21, 2026, will remain on the board, and receives severance benefits under the existing Severance and Change in Control Plan, a $35,000 lump-sum payment, and accelerated vesting of a 2024 restricted stock award pursuant to a release of claims.
The board appointed Jeff Hanson, previously Interim CEO and Chairman, as permanent CEO with a $965,000 base salary, target annual bonus equal to 160% of base salary, and time-based and performance-based RSU grants each with a grant date fair value of $2,072,534, subject to multi‑year vesting and performance conditions. COO Gabe Willhite was promoted to President and COO with a $100,000 cash compensation increase, a higher bonus target of 125% of annualized base compensation, and time- and performance-based RSUs each valued at $347,840. Director Scott Estes was named Lead Independent Director with an additional $40,000 annual cash retainer, and a press release describing these changes was furnished as an exhibit.
American Healthcare REIT, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 24, 2026. Stockholders elected nine directors to one-year terms expiring at the 2027 annual meeting, with each nominee receiving a majority of votes cast.
Stockholders also ratified the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the year ending December 31, 2026, with more than 172 million shares voted in favor. In addition, they approved, on an advisory and non-binding basis, the compensation paid to the company’s named executive officers for the year ended December 31, 2025.
No other proposals were submitted to a vote at the meeting.
American Healthcare REIT, Inc. declared a cash distribution for the second quarter of 2026. The board approved a quarterly distribution of $0.25 per share for the quarter ending June 30, 2026, which corresponds to an annualized rate of $1.00 per share.
The cash distribution will be paid on or about July 17, 2026 to stockholders of record as of the close of business on June 30, 2026, and will be made only from legally available funds. The company operates as a real estate investment trust focused on senior housing, skilled nursing facilities, and outpatient medical buildings in the U.S., the U.K., and the Isle of Man.
American Healthcare REIT, Inc. reports that the underwriter in its recent equity offering has fully exercised its option to purchase an additional 2,100,000 shares of common stock. These shares were sold on May 28, 2026 through a forward sale structure with an affiliate of BofA Securities, Inc.
The company intends to physically settle the additional forward sale agreement by delivering 2,100,000 shares to the forward purchaser by May 20, 2028 in exchange for cash based on the public offering price, less the underwriting discount and subject to adjustments. It plans to contribute the net proceeds to its operating partnership for general corporate purposes, including potential future investments.
American Healthcare REIT, Inc. closed a public offering of 14,000,000 shares of its common stock through a forward sale structure. BofA Securities acted as underwriter, forward seller, and, through an affiliate, forward purchaser, with a 30-day option to buy up to 2,100,000 additional shares.
Under a forward sale agreement dated May 20, 2026, the forward seller borrowed and sold 14,000,000 shares on May 22, 2026. The company expects to physically settle the agreement by delivering 14,000,000 shares to the forward purchaser by May 20, 2028 in exchange for cash based on the public offering price, less underwriting discounts and subject to adjustments.
The company intends to contribute the net cash from settlement to its operating partnership in exchange for units, and the operating partnership plans to use the funds for general corporate purposes, including potential future investments. The shares were issued under an effective Form S-3 shelf registration.
American Healthcare REIT, Inc. reported strong first quarter 2026 results, returning solid profitability and raising its full-year outlook. For the three months ended March 31, 2026, total revenues were $650.8 million, up from $540.6 million a year earlier, and net income attributable to controlling interest was $23.7 million, or $0.13 per diluted share, versus a loss of $0.04 per share last year.
Same-store NOI growth reached 12.1%, led by the senior housing businesses: ISHC grew 14.5%, SHOP 19.7%, with Triple-Net and Outpatient Medical up 4.6% and 1.6%, respectively. NAREIT FFO attributable to controlling interest rose to $90.4 million, or $0.48 per diluted share, and Normalized FFO increased to $94.8 million, or $0.50 per diluted share.
The company reported Adjusted EBITDA of $114.9 million and Net-Debt-to-Annualized Adjusted EBITDA of 3.0x. It entered and settled significant ATM equity forward sales, ending with $1.53 billion of total consolidated indebtedness and about $1.31 billion of liquidity. Full-year 2026 guidance was raised for NFFO per diluted share to $2.03–$2.09 and total portfolio same-store NOI growth to 9–12%. The quarterly cash distribution of $0.25 per share for Q1 2026 was paid on April 17, 2026.
American Healthcare REIT, Inc. amended its main corporate credit facility through a Second Amendment to its existing credit agreement. The updated 2026 Credit Agreement now provides a senior unsecured term loan of $550,000,000 maturing on January 19, 2027 and an enlarged revolving credit facility of $800,000,000.
The revolving loans mature on April 1, 2030, with two extension options to October 1, 2030 and April 1, 2031, subject to conditions including an extension fee. As of April 1, 2026, aggregate borrowing capacity under the amended facility was $1,350,000,000.
The facility is unsecured and bears interest at rates based on Daily Simple SOFR or Term SOFR plus an applicable margin, or a Base Rate alternative if SOFR cannot be determined. It includes customary financial covenants, such as leverage, net worth and coverage ratios, and allows repayment without prepayment penalties, while giving lenders acceleration rights in the event of default.
American Healthcare REIT is updating the pay package for Interim Chief Executive Officer and President Jeffrey T. Hanson. Under a new employment letter effective as of February 4, 2026, he will continue as both Interim CEO and Chairman of the Board until removed by the board.
Hanson will receive a base salary of $70,666.67 per month and an annual cash bonus opportunity for 2026 targeted at 120% of his annualized base salary, pro-rated for time served as Interim CEO. The agreement also grants two restricted stock unit awards, each with a grant date value of no less than $2,027,075, one time-based and one performance-based, with pro-rating if his interim service ends before December 31, 2026. This compensation replaces additional pay for his board service.
American Healthcare REIT, Inc. announced that its board of directors has authorized a first quarter 2026 cash distribution of $0.25 per share of common stock, equivalent to an annualized rate of $1.00 per share.
The distribution covers the quarter from January 1, 2026 through March 31, 2026 and will be paid on or about April 17, 2026 to stockholders of record at the close of business on March 31, 2026. The payment will be made only from legally available funds.
American Healthcare REIT, Inc. entered into a new at-the-market equity offering program allowing sales of up to $1.75 billion of common stock through multiple banks acting as agents or forward sellers. This replaces a prior program that had $230,139,575 of capacity remaining when it was terminated.
The company may also use forward sale agreements, under which forward purchasers borrow and sell shares, with the company later choosing physical, cash or net share settlement. Net cash proceeds the company ultimately receives are expected to be contributed to its operating partnership and used for general corporate purposes, including potential debt repayment, working capital, capital expenditures and future investments.
American Healthcare REIT, Inc. reported strong fourth quarter and full-year 2025 results and issued 2026 guidance. Same-store NOI grew 11.8% in Q4 2025 and 14.2% for the year, led by 18.4% ISHC and 25.2% SHOP segment growth.
Full-year net income attributable to controlling interest was $69.8 million, or $0.42 per diluted share, versus a loss in 2024. NAREIT FFO per diluted share rose to $1.76 from $1.26, and Normalized FFO per diluted share increased to $1.72 from $1.41.
The company completed over $950 million of 2025 acquisitions, expects approximately $178 million of development spend (with $66.9 million funded), and ended 2025 with $1.54 billion of consolidated debt, Net-Debt-to-Annualized Adjusted EBITDA of 3.4x, and about $1.14 billion of liquidity.
For 2026, guidance targets diluted net income per share of $0.75–$0.81, NAREIT FFO per share of $1.93–$1.99, Normalized FFO per share of $1.99–$2.05, and total portfolio same-store NOI growth of 7–11%, with SHOP same-store NOI growth of 15–19%.
American Healthcare REIT, Inc. announced that Chief Executive Officer, President and director Danny Prosky is taking a leave of absence effective February 3, 2026 due to a recent medical event. The board appointed Jeffrey T. Hanson, Chairman of the Board and former Chief Executive Officer from 2015 to 2021, as Interim Chief Executive Officer and President, also effective February 3, 2026. The company issued a press release on February 4, 2026 describing these leadership changes, which is included as an exhibit to this report.
American Healthcare REIT, Inc. reported that its board of directors authorized a fourth quarter 2025 cash distribution of $0.25 per share of common stock. This quarterly amount corresponds to an annualized distribution rate of $1.00 per share for the period from October 1, 2025 through December 31, 2025.
The distribution will be paid in cash on or about January 16, 2026 to stockholders of record as of the close of business on December 31, 2025. The company also made available a press release with additional details as an exhibit to this report.
American Healthcare REIT, Inc. entered into an additional forward sale agreement covering 1,215,000 shares of its common stock in connection with the full exercise of the underwriter’s option from a previously closed public offering of 8,100,000 shares. A forward seller borrowed and sold these 1,215,000 shares to hedge the forward purchaser’s obligations.
The company currently plans to deliver 1,215,000 shares to the forward purchaser on one or more dates no later than May 20, 2027, in exchange for cash based on the public offering price, less underwriting discounts and commissions and subject to adjustments. The company intends to contribute the net proceeds to its operating partnership, which plans to use the funds for general corporate purposes, including potential future investments.
American Healthcare REIT, Inc. closed a public offering of 8,100,000 shares of its common stock through a forward sale structure. Under an underwriting agreement with RBC Capital Markets and an affiliate acting as forward purchaser, the shares were borrowed and sold on November 24, 2025 to hedge the forward sale agreement.
The company expects, subject to its right to elect cash or net share settlement, to deliver 8,100,000 shares to the forward purchaser on one or more dates no later than May 20, 2027 in exchange for cash proceeds per share based on the public offering price, less underwriting discounts and commissions and subject to adjustments. The underwriters also have a 30-day option to purchase up to 1,215,000 additional shares.
The company intends to contribute the net proceeds from settling the forward sale agreement to its operating partnership in exchange for limited partnership units, and the operating partnership plans to use these funds for general corporate purposes, including potential future investments.
American Healthcare REIT, Inc. (AHR) furnished an 8-K announcing its quarterly disclosures. The company released its earnings press release for the quarter ended September 30, 2025 and issued a Q3 2025 supplemental package.
The materials are provided under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD). Exhibits include 99.1 (Earnings Release) and 99.2 (Third Quarter 2025 Supplemental). The information in Items 2.02 and 7.01 is being furnished, not filed.
American Healthcare REIT, Inc. reported that its board of directors authorized a third quarter 2025 cash distribution for common stockholders. The distribution covers the period from July 1, 2025 through September 30, 2025 and is set at $0.25 per share, which the company states is equal to an annualized distribution rate of $1.00 per share. Stockholders of record as of the close of business on September 30, 2025 will be eligible to receive the payment. The company expects to pay the distribution in cash on or about October 17, 2025, and notes that it will be paid only from legally available funds.
American Healthcare REIT, Inc. entered into an at-the-market (ATM) equity offering sales agreement that allows the company to offer and sell up to $1.0 billion of its common stock through a group of major investment banks acting as agents or, if applicable, as forward sellers or purchasers. The agreement replaces the prior ATM program, which had no remaining unsold shares, and permits sales in negotiated block trades, ordinary brokers' transactions at prevailing market prices, on exchanges, or through electronic networks.
The agents may earn commissions up to 2.0% of gross sales price, and the company may also sell shares directly to agents as principals or enter into forward sale agreements with specified forward purchasers. Forward sale mechanics include daily interest-rate-based adjustments and decreases for expected dividends; the company will not receive proceeds from shares borrowed and sold by a Forward Purchaser. Net proceeds are expected to be contributed to the registrant's Operating Partnership for general corporate purposes, including debt repayment, working capital, capital expenditures, and potential investments.
American Healthcare REIT (NYSE:AHR) filed an 8-K disclosing results from its June 25, 2025 Annual Meeting.
- Nine directors were re-elected for one-year terms ending in 2026.
- Shareholders ratified Deloitte & Touche LLP as independent auditor for FY 2025 (138.4 M for / 1.1 M against).
- Say-on-pay for 2024 executive compensation passed (109.3 M for / 7.5 M against).
- The 2025 Manager Equity Plan was approved (112.6 M for / 4.3 M against).
No other matters were brought to a vote.
On June 20, 2025, American Healthcare REIT, Inc. (NYSE: AHR) filed a Form 8-K to announce its second-quarter 2025 cash distribution.
The board authorized a quarterly dividend of $0.25 per common share, equal to an annualized rate of $1.00. Shareholders of record at the close of business on June 30, 2025, will receive the payment on or about July 18, 2025, funded solely from legally available funds.
No additional financial results, transactions, or strategic updates were disclosed in this report.